JP2005538380A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538380A5
JP2005538380A5 JP2004536454A JP2004536454A JP2005538380A5 JP 2005538380 A5 JP2005538380 A5 JP 2005538380A5 JP 2004536454 A JP2004536454 A JP 2004536454A JP 2004536454 A JP2004536454 A JP 2004536454A JP 2005538380 A5 JP2005538380 A5 JP 2005538380A5
Authority
JP
Japan
Prior art keywords
specimen
antibody
specifically
sbdp145
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004536454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/028406 external-priority patent/WO2004025298A1/en
Publication of JP2005538380A publication Critical patent/JP2005538380A/ja
Publication of JP2005538380A5 publication Critical patent/JP2005538380A5/ja
Pending legal-status Critical Current

Links

JP2004536454A 2002-09-11 2003-09-11 神経細胞損傷の分析 Pending JP2005538380A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40992002P 2002-09-11 2002-09-11
PCT/US2003/028406 WO2004025298A1 (en) 2002-09-11 2003-09-11 Analyzing nerve cell damage

Publications (2)

Publication Number Publication Date
JP2005538380A JP2005538380A (ja) 2005-12-15
JP2005538380A5 true JP2005538380A5 (https=) 2007-12-13

Family

ID=31994033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536454A Pending JP2005538380A (ja) 2002-09-11 2003-09-11 神経細胞損傷の分析

Country Status (6)

Country Link
US (1) US7291710B2 (https=)
EP (3) EP2348317B1 (https=)
JP (1) JP2005538380A (https=)
AU (1) AU2003270509B2 (https=)
CA (1) CA2498614C (https=)
WO (1) WO2004025298A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207033B1 (en) * 2004-04-15 2014-06-18 University of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
CA2578680C (en) * 2004-04-15 2011-06-14 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
JP5202296B2 (ja) * 2005-04-01 2013-06-05 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド 肝臓傷害のバイオマーカー
US8048638B2 (en) * 2005-04-01 2011-11-01 University Of Florida Research Foundation, Inc. Biomarkers of liver injury
EP1840574A1 (en) 2006-03-30 2007-10-03 Institut Pasteur Use of the alpha chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
CN101983337A (zh) * 2008-02-04 2011-03-02 班扬生物标记公司 用于诊断或治疗脑损伤的方法
US12601749B2 (en) 2008-08-11 2026-04-14 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
US20140342381A1 (en) * 2008-08-11 2014-11-20 Banyan Biomarkers, Inc. Devices and methods for biomarker detection process and assay of neurological condition
ES2665245T3 (es) 2008-08-11 2018-04-25 Banyan Biomarkers, Inc. Proceso de detección de biomarcador y ensayo de estado neurológico
EP3355059A3 (en) 2009-06-19 2018-09-26 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
WO2011032155A2 (en) 2009-09-14 2011-03-17 Banyan Biomarkers, Inc. Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
WO2012141674A2 (en) 2010-01-26 2012-10-18 Banyan Biomarkers, Inc. Compositions and methods relating to argininosuccinate synthetase
JP2013524220A (ja) * 2010-04-01 2013-06-17 バンヤン・バイオマーカーズ・インコーポレイテッド 神経毒性を検出するためのマーカーおよびアッセイ
CA2939692C (en) 2013-03-15 2022-10-18 The Trustees Of The University Of Pennsylvania Blood biomarkers that predict persistent cognitive dysfunction after concussion
WO2015066211A1 (en) * 2013-10-29 2015-05-07 Banyan Biomarkers, Inc. Uch-l1 isoforms, assays and devices for detection of a neurological condition
WO2018081649A1 (en) 2016-10-28 2018-05-03 Banyan Biomarkers, Inc. Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118606A (en) * 1988-09-02 1992-06-02 The Regents Of The University Of California Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
US5116606A (en) * 1989-03-09 1992-05-26 Alt John P Skin treatment method and solution
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
EP0786469B1 (en) 1990-06-11 2006-03-01 Gilead Sciences, Inc. Methods of use of nucleic acid ligands
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products

Similar Documents

Publication Publication Date Title
JP2005538380A5 (https=)
WO2004070020A3 (en) Glyphosate tolerant alfalfa events and methods for detection thereof
EP1860186A3 (en) Method for distinguishing mesenchymal stem cells using different markers
WO2005111243A3 (en) Multiplexed detection of biological agents
DE60045796D1 (de) Gesamt-chromosom analyse von protein-dns wechselwirkungen
CA2647042A1 (en) Protein isoform discrimination and quantitative measurements thereof
AU3625999A (en) Detection of a target in a sample
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
DE602004011105D1 (de) Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
WO2003012068A3 (en) Novel fusion proteins and assays for molecular binding
WO2006117161A3 (en) New labelling strategies for the sensitive detection of analytes
WO2005042771A3 (en) Colorimetric substrates, colorimetric sensors, and methods of use
WO2007133704A3 (en) A non-nucleic acid based biobarcode assay for detection of biological materials
JP2005521411A5 (https=)
US20160282345A1 (en) Identification of secreted proteins as detection markers for citrus disease
WO2003031054A3 (en) Arrays having clustered arrangements and methods of making and using them
ATE553386T1 (de) Bluttypisierung
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
WO2003060098A3 (en) Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
WO2002083929A3 (en) System and method for quantitating transcription factors
WO2002071073A3 (en) Screening system based on expression of abcg2 half transporter protein
EP1914320A3 (en) A method for detection of one or more CpG positions
WO2004023146A3 (en) Methods for assaying protein-protein interactions
EP1945798B1 (de) Verfahren zur bestimmung der spaltbarkeit von substraten
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit